Circular Genomics uses RNA to stop depression meds being a guessing game

jaya40436
Oct 18, 2022
1 min read

Updated: Jul 23, 2024

October 18, 2022 (TechCrunch) -- For many people who live with depression, medication is an important part of managing the condition. But knowing which will work for you can be a difficult months-long process. Circular Genomics claims its new form of genetic testing can identify which medications will work for a patient in a fraction of that time.

View Remaining Article on TechCrunch

Paul Sargeant, PhD, CEO of Circular Genomics Presents at LSI USA '25 - "Circular RNA Biomarkers for Depression Treatment"

Circular Genomics is at the forefront of revolutionizing healthcare by leveraging circular RNA to develop advanced diagnostic tools,...

5 Promising RNA Biotech Companies To Watch in 2025

Circular Genomics: Innovative RNA Solutions to Lead a New Era in Mental Health RNA, often referred to as the “messenger molecule,” plays...

Podcast: "Revolutionizing Depression Treatment with Dr. Nikolaos Mellios"

Circular Genomics' Chief Scientific Officer, Dr. Nikolaos Mellios, M.D., PhD, joins Steven Schwartz on the Concierge Medical Marketing...

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.